AbbVie
ABBV
#26
Rank
S$476.93 B
Marketcap
$270.01
Share price
0.06%
Change (1 day)
39.70%
Change (1 year)

The biotechnology and pharmaceutical company Abbvie, spelled AbbVie, was founded in 2013 as a spin-off from Abbott Laboratories and is traded on the NYSE stock exchange in the S&P 100 index under the symbol โ€œABBVโ€.

Market capitalization of AbbVie (ABBV)

Market cap: S$476.93 Billion

As of November 2024 AbbVie has a market cap of S$476.93 Billion. This makes AbbVie the world's 26th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of AbbVie from 2012 to 2024

End of year Market Cap

Year Marketcap Change
2024S$476.93 B31.99%
2023S$361.35 B-5.69%
2022S$383.14 B18.4%
2021S$323.60 B29.31%
2020S$250.26 B41.76%
2019S$176.53 B-5.22%
2018S$186.25 B-9.8%
2017S$206.49 B40.21%
2016S$147.28 B9.18%
2015S$134.90 B-1.96%
2014S$137.60 B29.56%
2013S$106.20 B60.91%
2012S$66.00 B

End of Day market cap according to different sources

On Oct 31st, 2024 the market cap of AbbVie was reported to be:

S$476.62 Billion
by Yahoo Finance info icon info icon
S$476.62 Billion
by CompaniesMarketCap info icon info icon
S$476.60 Billion
by Nasdaq info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
S$211.02 B-55.75%๐Ÿ‡บ๐Ÿ‡ธ USA
S$146.39 B-69.30%๐Ÿ‡บ๐Ÿ‡ธ USA
S$1.030 T 115.99%๐Ÿ‡บ๐Ÿ‡ธ USA
S$227.35 B-52.33%๐Ÿ‡บ๐Ÿ‡ธ USA
S$147.48 B-69.08%๐Ÿ‡บ๐Ÿ‡ธ USA
S$33.49 B-92.98%๐Ÿ‡บ๐Ÿ‡ธ USA
S$99.75 B-79.08%๐Ÿ‡ฌ๐Ÿ‡ง UK
S$300.26 B-37.04%๐Ÿ‡ฌ๐Ÿ‡ง UK
S$16.31 B-96.58%๐Ÿ‡บ๐Ÿ‡ธ USA